Pharma Pulse
FROM REAL WORLD TO REAL IMPACT
Transforming Trials in the Era of RWE in Asia-Pacific
APAC houses almost per cent of the worlds population However less than per cent of global trials are conducted
SUPPLY WITH CARE
Crafting strategies for clinical trial excellence in the Asia-Pacific – A CDMO Perspective
Business continuity must also be a priority Unplanned events can occur in limitless ways from disease outbreaks
GenAI's Impact on Reshaping the Pharma Industry
From my vantage point over the past year the initial hype as well as the wariness around GenAI has started to settle into cautious optimism
